Capital Fund Management S.A. increased its holdings in Itron, Inc. (NASDAQ:ITRI - Free Report) by 41.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 52,954 shares of the scientific and technical instruments company's stock after acquiring an additional 15,515 shares during the quarter. Capital Fund Management S.A. owned approximately 0.12% of Itron worth $5,750,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Proficio Capital Partners LLC purchased a new stake in shares of Itron in the 4th quarter worth approximately $30,000. Hager Investment Management Services LLC purchased a new stake in Itron during the fourth quarter worth $67,000. Contravisory Investment Management Inc. increased its holdings in shares of Itron by 154.9% in the 4th quarter. Contravisory Investment Management Inc. now owns 864 shares of the scientific and technical instruments company's stock valued at $94,000 after acquiring an additional 525 shares during the period. Smartleaf Asset Management LLC raised its position in shares of Itron by 347.5% in the 4th quarter. Smartleaf Asset Management LLC now owns 886 shares of the scientific and technical instruments company's stock worth $97,000 after acquiring an additional 688 shares in the last quarter. Finally, GAMMA Investing LLC lifted its stake in shares of Itron by 15.6% during the 4th quarter. GAMMA Investing LLC now owns 1,177 shares of the scientific and technical instruments company's stock worth $128,000 after purchasing an additional 159 shares during the last quarter. 96.19% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In other Itron news, CAO David Marshall Wright sold 317 shares of the business's stock in a transaction on Monday, February 24th. The shares were sold at an average price of $92.90, for a total transaction of $29,449.30. Following the sale, the chief accounting officer now directly owns 8,108 shares in the company, valued at approximately $753,233.20. The trade was a 3.76 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Christopher E. Ware sold 648 shares of the stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $92.90, for a total transaction of $60,199.20. Following the completion of the transaction, the senior vice president now owns 20,326 shares of the company's stock, valued at $1,888,285.40. This represents a 3.09 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 4,037 shares of company stock valued at $385,815 over the last 90 days. Insiders own 1.45% of the company's stock.
Itron Stock Performance
ITRI traded down $0.43 during trading on Wednesday, reaching $101.65. 454,977 shares of the company's stock were exchanged, compared to its average volume of 569,240. The company's fifty day simple moving average is $102.21 and its 200-day simple moving average is $107.44. The stock has a market capitalization of $4.63 billion, a P/E ratio of 20.83, a price-to-earnings-growth ratio of 0.81 and a beta of 1.39. The company has a debt-to-equity ratio of 0.91, a current ratio of 3.36 and a quick ratio of 2.83. Itron, Inc. has a 1 year low of $88.92 and a 1 year high of $124.90.
Wall Street Analysts Forecast Growth
Several research firms have commented on ITRI. Oppenheimer increased their price target on shares of Itron from $124.00 to $131.00 and gave the company an "outperform" rating in a research report on Wednesday, February 26th. Guggenheim lowered their target price on shares of Itron from $135.00 to $133.00 and set a "buy" rating for the company in a research note on Thursday, February 27th. StockNews.com lowered Itron from a "strong-buy" rating to a "buy" rating in a report on Saturday, March 1st. Canaccord Genuity Group boosted their target price on Itron from $130.00 to $132.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Finally, Piper Sandler increased their price target on Itron from $119.00 to $124.00 and gave the company a "neutral" rating in a research note on Thursday, February 27th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $127.64.
Check Out Our Latest Stock Report on Itron
Itron Company Profile
(
Free Report)
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
Read More

Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.